Used as a key chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) for drugs targeting neurological and metabolic disorders. Its structure supports the formation of peptide-like frameworks, making it valuable in medicinal chemistry for designing enzyme inhibitors. Commonly employed in the production of dipeptidyl peptidase-4 (DPP-4) inhibitors used in type 2 diabetes treatments. The compound’s functional groups allow for selective coupling reactions, enabling efficient construction of complex molecules in multi-step synthetic routes.